• ქართული
  • English
  • AbbVie says Humira rivals from Biogen, Amgen most aggressive so far

    AbbVie Inc’s Chief Executive Officer Richard Gonzalez said on a conference call that rivals Biogen Inc and Amgen Inc had been the most aggressive in Europe with their biosimilar versions of its blockbuster drug Humira.

    Market Quotes by TradingView